Reference data : LOINC code

Filter

Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType		Clear filter
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType

Results

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page

Loinc Number	Component	Property	System	Time aspect	ScaleType	MethodType	Relat_nms	loincStatus	Long Common name	answerList	chngType	DefinitionDescription	dtLastCh	exactCmspy	exampleUnits	exmplAnswers	externalCopyrightNotice	formula	hl7FieldSubfieldId	InpcPercentage	ipccUnits	loincClass	loincFinal	loincNum	mapTo	methodTyp	molarMass	naaccrId	orderObs	panelElements	reference	scope	setRoot	shortName	source	surveyQuestSrc	surveyQuestText	unitsRequired	acssym	relatedNames2	VersionLastChanged	VersionFirstRelease	ValidHL7AttachmentRequest	PanelType	AssociatedObservations	EXTERNAL_COPYRIGHT_LINK	HL7_ATTACHMENT_STRUCTURE	CONSUMER_NAME	EXAMPLE_UCUM_UNITS	STATUS_REASON	STATUS_TEXT	CHANGE_REASON_PUBLIC	COMMON_TEST_RANK	COMMON_ORDER_RANK
47177-1	Parathyrin.intact^5M post excision	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Parathyrin.intact [Moles/volume] in Serum or Plasma --5 minutes post excision		MIN	DefinitionDescription			pmol/L							CHAL		47177-1					Observation				0	PTH-Intact 5m p Excision SerPl-sCnc				N		5m p Excision; After; CHEMISTRY.CHALLENGE TESTING; Intact Parathormone; intact parathyroid hormone; iPTH; Level; p Excision; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; post surgery; PST; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	2.7	2.19								pmol/L				0
47178-9	Parathyrin.intact^baseline	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Parathyrin.intact [Moles/volume] in Serum or Plasma --baseline		MIN	DefinitionDescription			pmol/L							CHAL		47178-9					Both				0	PTH-Intact BS SerPl-sCnc				N		BS; CHEMISTRY.CHALLENGE TESTING; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	2.7	2.19								pmol/L				0
47179-7	Parathyrin^10M post excision	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Parathyrin [Moles/volume] in Serum or Plasma --10 minutes post excision		MIN	DefinitionDescription			pmol/L							CHAL		47179-7					Observation				0	PTH 10m p Excision SerPl-sCnc				N		10m p Excision; After; CHEMISTRY.CHALLENGE TESTING; Level; p Excision; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; post surgery; PST; PTH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								pmol/L				0
4718-3	HLA-A1	PrThr	Bld/Tiss	Pt	Ord			ACTIVE	HLA-A1 [Presence]		MIN	DefinitionDescription										HLA		4718-3					Observation				0	HLA-A1 Ql						Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.73	1											This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
47180-5	Parathyrin^baseline	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Parathyrin [Moles/volume] in Serum or Plasma --baseline		MIN	DefinitionDescription			pmol/L							CHAL		47180-5					Observation				0	PTH BS SerPl-sCnc				N		BS; CHEMISTRY.CHALLENGE TESTING; Level; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								pmol/L				0
47181-3	Progesterone^1.5H post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47181-3					Observation				0	Progest 1.5h p chal SerPl-sCnc				N		1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								nmol/L				0
47182-1	Progesterone^10th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47182-1					Observation				0	Progest sp10 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp10; sp10 p chal; Spec; SR; Substance concentration	2.7	2.19								nmol/L				0
47183-9	Progesterone^15M post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47183-9					Observation				0	Progest 15M p chal SerPl-sCnc				N		15M p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								nmol/L				0
47184-7	Progesterone^1H post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47184-7					Observation				0	Progest 1h p chal SerPl-sCnc				N		1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								nmol/L				0
47185-4	Progesterone^2H post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47185-4					Observation				0	Progest 2h p chal SerPl-sCnc				N		120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								nmol/L				0
47186-2	Progesterone^30M post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47186-2					Observation				0	Progest 30M p chal SerPl-sCnc				N		30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								nmol/L				0
47187-0	Progesterone^45M post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47187-0					Observation				0	Progest 45M p chal SerPl-sCnc				N		45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								nmol/L				0
47188-8	Progesterone^5th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47188-8					Observation				0	Progest sp5 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR; Substance concentration	2.7	2.19								nmol/L				0
47189-6	Progesterone^baseline	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Progesterone [Moles/volume] in Serum or Plasma --baseline		MIN	DefinitionDescription			nmol/L							CHAL		47189-6					Observation				0	Progest BS SerPl-sCnc				N		BS; CHEMISTRY.CHALLENGE TESTING; Level; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								nmol/L				0
4719-1	HLA-A23(9)	PrThr	Bld/Tiss^Donor	Pt	Ord			ACTIVE	HLA-A23(9) [Presence] in Donor		MAJ	DefinitionDescription										HLA		4719-1					Observation				0	HLA-A23(9) Donr Ql						Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	1											This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
47190-4	Proinsulin^baseline	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Proinsulin [Moles/volume] in Serum or Plasma --baseline		MIN	DefinitionDescription			pmol/L							CHAL		47190-4					Observation				0	Proinsulin BS SerPl-sCnc				N		BS; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; Pro insulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.19								pmol/L				0
47191-2	Triiodothyronine^2nd specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge		MIN	DefinitionDescription			pmol/L;nmol/L							CHAL		47191-2					Observation				0	T3 sp2 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR; Substance concentration; T3; T-3; thyroid hormone; Total T3; Triodothyrne	2.7	2.19								nmol/L				0
47192-0	Triiodothyronine^3rd specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge		MIN	DefinitionDescription			pmol/L;nmol/L							CHAL		47192-0					Observation				0	T3 sp3 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR; Substance concentration; T3; T-3; thyroid hormone; Total T3; Triodothyrne	2.7	2.19								nmol/L				0
47193-8	Triiodothyronine^4th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge		MIN	DefinitionDescription			pmol/L;nmol/L							CHAL		47193-8					Observation				0	T3 sp4 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR; Substance concentration; T3; T-3; thyroid hormone; Total T3; Triodothyrne	2.7	2.19								nmol/L				0
47194-6	Triiodothyronine^5th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge		MIN	DefinitionDescription			pmol/L;nmol/L							CHAL		47194-6					Observation				0	T3 sp5 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR; Substance concentration; T3; T-3; thyroid hormone; Total T3; Triodothyrne	2.7	2.19								nmol/L				0
47195-3	Triiodothyronine^6th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge		MIN	DefinitionDescription			pmol/L;nmol/L							CHAL		47195-3					Observation				0	T3 sp6 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR; Substance concentration; T3; T-3; thyroid hormone; Total T3; Triodothyrne	2.7	2.19								nmol/L				0
47196-1	Triiodothyronine^7th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge		MIN	DefinitionDescription			pmol/L;nmol/L							CHAL		47196-1					Observation				0	T3 sp7 p chal SerPl-sCnc				N		^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR; Substance concentration; T3; T-3; thyroid hormone; Total T3; Triodothyrne	2.7	2.19								nmol/L				0
47197-9	Triiodothyronine^8th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge		MIN	DefinitionDescription			pmol/L;nmol/L							CHAL		47197-9					Observation				0	T3 sp8 p chal SerPl-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR; Substance concentration; T3; T-3; thyroid hormone; Total T3; Triodothyrne	2.7	2.19								nmol/L				0
47198-7	Vasopressin^1st specimen post XXX challenge	MCnc	Plas	Pt	Qn			ACTIVE	Vasopressin [Mass/volume] in Plasma --1st specimen post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		47198-7					Observation				0	Vasopressin sp1 p chal Plas-mCnc				N		Acute specimen; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; sp1; sp1 p chal; Spec; VP	2.7	2.19								pg/mL				0
47199-5	Methionine	Mass	Dose	Pt	Qn			ACTIVE	Methionine [Mass] of Dose		MIN	DefinitionDescription										DRUGDOSE		47199-5					Observation				0	Methionine Dose				N		Dose med or substance; DRUG DOSES; Met; Point in time; QNT; Quan; Quant; Quantitative; Random	2.69	2.19								mg				0

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page